Mathys & Squire v Astellas (CFI, 28 December 2023)

Date	28 December 2023
Court	CFI
Division	Munich (DE) Central Division - Section
Type of action	Application RoP262.1 (b)
Case number(s)	UPC_CFI_75/2023
Registry reference	App_588681/2023 · UPC_CFI_75/2023
Parties	Mathys & Squire v. Astellas, Healios, Riken, Osaka University

Summary pending review. Official UPC registry metadata imported on 24 September 2026.

Official decision (PDF) · UPC registry entry

Case timeline

21 September 2023 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 September 2023) ORD_552745/2023 · UPC_CFI_75/2023
11 October 2023 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_75/2023, 11 October 2023) ORD_579543/2023 · UPC_CFI_75/2023
18 March 2024 : Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) ACT_464985/2023 · ORD_598255/2023 · UPC_CFI_75/2023
22 August 2024 : Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) App_588681/2023 · ORD_591107/2023 · UPC_CFI_75/2023

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

English summary awaiting review. Read the French case note.

Source and translations

Official source: Unified Patent Court registry link recorded in the record
Original language: not recorded
Translation available: no translation recorded the firm’s French record is a summary, not a translation
Date checked: not recorded

Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

UPC_CFI_75/2023 official number

Follow this case

Parties

defendantAstellas2 decisions in the corpus Follow this party
defendantRikennormalised name: RIKEN7 decisions in the corpus Follow this party
defendantOsaka Universitynormalised name: OSAKA UNIVERSITY9 decisions in the corpus Follow this party
claimantMathys & SquireFollow this party
defendantHealiosFollow this party

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

21 September 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 September 2023) Revocation Action · UPC_CFI_75/2023
La demande d'accès d'un tiers au mémoire introductif et à la lettre de signification est rejetée : l'éducation et la formation ne sont pas un motif légitime, et la lettre n'est ni une écriture ni une pièce.
11 October 2023 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_75/2023, 11 October 2023) Revocation Action · UPC_CFI_75/2023
Le mémoire en défense à l'action en nullité est réputé signifié le 29 septembre 2023, la notification générée par le CMS valant signification au sens de la règle 278.1.
28 December 2023 Mathys & Squire v Astellas (CFI, 28 December 2023) Application RoP262.1 (b) · UPC_CFI_75/2023
18 March 2024 Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) Revocation Action · UPC_CFI_75/2023
Le document D18 est admis sous réserve d'une réponse de la défenderesse avant le 11 avril 2024, la valeur du litige est fixée à 4 000 000 euros et l'audience confirmée au 25 juin 2024.
22 August 2024 Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) Application RoP262.1 (b) · UPC_CFI_75/2023
Mathys & Squire obtient l'accès aux écritures et pièces de l'action en nullité close par transaction, après occultation des données personnelles et des informations confidentielles d'Astellas. L'appel est autorisé.

What the record states

Nature of the act: Application RoP262.1 (b)
Outcome (Dhenne Avocats summary): La demande d'accès de Mathys & Squire est mise en attente jusqu'à la décision de la cour d'appel sur la règle 262.1 b), à produire dans les trois semaines.
Appeal: No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance: First-instance decision, whether it has become final is not recorded.

Patents mentioned

EP 3 056 563 mentioned in: Dhenne Avocats analysis Follow this patent

Related decisions cited in the analyses

Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 August 2024) cited in this record
Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 March 2024) cited in this record
Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_CFI_75/2023, 11 October 2023) cited in this record
Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 September 2023) cited in this record
Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_464985/2023, 16 June 2023) cited in this record

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

Publication	Role in the dispute	Family	Standard and declaration	Pool	Sources
`EP 3 056 563` Method of producing retinal pigment epithelial cell recorded proprietor: Healios KK, RIKEN et University of Osaka NUC	Mentioned in the analysis (role not qualified) Also mentioned in 7 other decision(s): Mathys & Squire v Astellas Institute for Regenerative Medicine (CFI, 4 · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 22 Au · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 23 Ju · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, 18 M · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, UPC_C · Astellas Institute for Regenerative Medicine v Healios K.K (CFI, 21 Se · Astellas Institute for Regenerative Medicine v Healios K.K. (CFI, ORD_	not recorded	not recorded	not recorded	Espacenet · European Patent Register existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically) mentioned in: Dhenne Avocats analysis

The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.